The Discounted Cash Flow (DCF) valuation of Amicus Therapeutics Inc (FOLD) is 0.18 USD. With the latest stock price at 6.10 USD, the upside of Amicus Therapeutics Inc based on DCF is -97.1%.
Based on the latest price of 6.10 USD and our DCF valuation, Amicus Therapeutics Inc (FOLD) is a sell. selling FOLD stocks now will result in a potential gain of 97.1%.
| Range | Selected | |
| WACC / Discount Rate | 6.8% - 10.6% | 8.7% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (0.13) - 1.47 | 0.18 |
| Upside | -102.2% - -75.9% | -97.1% |